DrugCite
Search

ESKALITH

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Eskalith Adverse Events Reported to the FDA Over Time

How are Eskalith adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Eskalith, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Eskalith is flagged as the suspect drug causing the adverse event.

Most Common Eskalith Adverse Events Reported to the FDA

What are the most common Eskalith adverse events reported to the FDA?

Diarrhoea
27 (3.61%)
Mania
24 (3.21%)
Tremor
24 (3.21%)
Drug Ineffective
22 (2.94%)
Renal Failure
17 (2.27%)
Insomnia
13 (1.74%)
Vomiting
13 (1.74%)
Dizziness
12 (1.6%)
Therapeutic Agent Toxicity
12 (1.6%)
Weight Increased
12 (1.6%)
Nausea
10 (1.34%)
Show More Show More
Alopecia
9 (1.2%)
Depression
9 (1.2%)
Anxiety
8 (1.07%)
Asthenia
7 (.94%)
Drug Level Increased
7 (.94%)
Fatigue
7 (.94%)
Mental Status Changes
7 (.94%)
Confusional State
6 (.8%)
Dehydration
6 (.8%)
Hypothyroidism
6 (.8%)
Adverse Event
5 (.67%)
Agitation
5 (.67%)
Drug Interaction
5 (.67%)
Headache
5 (.67%)
Lethargy
5 (.67%)
Renal Disorder
5 (.67%)
Thyroid Disorder
5 (.67%)
Weight Decreased
5 (.67%)
Accidental Overdose
4 (.53%)
Convulsion
4 (.53%)
Depressed Level Of Consciousness
4 (.53%)
Disturbance In Attention
4 (.53%)
Dry Mouth
4 (.53%)
Psychotic Disorder
4 (.53%)
Somnolence
4 (.53%)
Suicidal Ideation
4 (.53%)
Suicide Attempt
4 (.53%)
Urinary Tract Infection
4 (.53%)
White Blood Cell Count Increased
4 (.53%)
Abdominal Pain Upper
3 (.4%)
Abnormal Behaviour
3 (.4%)
Aggression
3 (.4%)
Antipsychotic Drug Level Below Ther...
3 (.4%)
Antipsychotic Drug Level Increased
3 (.4%)
Blood Creatinine Increased
3 (.4%)
Constipation
3 (.4%)
Diabetes Insipidus
3 (.4%)
Dialysis
3 (.4%)
Disorientation
3 (.4%)
Drug Administration Error
3 (.4%)
Drug Effect Decreased
3 (.4%)
Drug Exposure During Pregnancy
3 (.4%)
Drug Level Below Therapeutic
3 (.4%)
Drug Level Decreased
3 (.4%)
Dyspnoea
3 (.4%)
Extrapyramidal Disorder
3 (.4%)
Feeling Abnormal
3 (.4%)
Hyperhidrosis
3 (.4%)
Hypokalaemia
3 (.4%)
Loss Of Consciousness
3 (.4%)
Malaise
3 (.4%)
Mental Disorder
3 (.4%)
Mood Swings
3 (.4%)
Myalgia
3 (.4%)
Oral Discomfort
3 (.4%)
Panic Attack
3 (.4%)
Pollakiuria
3 (.4%)
Psoriasis
3 (.4%)
Pyrexia
3 (.4%)
Renal Failure Chronic
3 (.4%)
Renal Impairment
3 (.4%)
Sedation
3 (.4%)
Sleep Disorder
3 (.4%)
Tachycardia
3 (.4%)
Thyroid Function Test Abnormal
3 (.4%)
Tinnitus
3 (.4%)
Acne
2 (.27%)
Affect Lability
2 (.27%)
Alanine Aminotransferase Increased
2 (.27%)
Aphasia
2 (.27%)
Back Pain
2 (.27%)
Bipolar Disorder
2 (.27%)
Bipolar I Disorder
2 (.27%)
Blood Glucose Increased
2 (.27%)
Blood Potassium Decreased
2 (.27%)
Blood Thyroid Stimulating Hormone D...
2 (.27%)
Bronchopneumonia
2 (.27%)
Burning Sensation
2 (.27%)
Chest Pain
2 (.27%)
Dental Caries
2 (.27%)
Diabetes Mellitus
2 (.27%)
Drug Toxicity
2 (.27%)
Dry Eye
2 (.27%)
Dry Skin
2 (.27%)
Dysarthria
2 (.27%)
Electrocardiogram Qt Prolonged
2 (.27%)
Erectile Dysfunction
2 (.27%)
Erythema Of Eyelid
2 (.27%)
Eye Irritation
2 (.27%)
Fall
2 (.27%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Eskalith, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Eskalith is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Eskalith

What are the most common Eskalith adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Eskalith, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Eskalith is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Eskalith According to Those Reporting Adverse Events

Why are people taking Eskalith, according to those reporting adverse events to the FDA?

Bipolar Disorder
79
Drug Use For Unknown Indication
54
Bipolar I Disorder
28
Depression
17
Ill-defined Disorder
13
Affective Disorder
6
Show More Show More
Schizophrenia
3
Schizophrenia, Paranoid Type
3
Mania
3
Bipolar Ii Disorder
3
Schizoaffective Disorder
2
Anger
2
Dementia
1
Product Used For Unknown Indication
1
Infection
1
Drug Therapy
1

Eskalith Case Reports

What Eskalith safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Eskalith. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Eskalith.